Intracavitary brachytherapy

RADIATION5 trials

Sponsors

Radiation Therapy Oncology Group, Stanford University, Barts & The London NHS Trust, Peking Union Medical College Hospital, Sir Run Run Shaw Hospital

Conditions

Breast CancerCarcinoma, DuctalCervical CancerLocally Advanced Cervical CancerRadiation ToxicityRectal AdenocarcinomaUterine Cervical Neoplasms

Phase 1

Radiation Therapy and Cisplatin With or Without Amifostine for Patients With Stage IIIB or IVA Cervical Cancer

CompletedNCT00012012

Radiation Therapy Oncology GroupCervical Cancer, Radiation Toxicity

Start: 2001-08-31End: 2010-06-30Updated: 2015-01-07

Dose Escalation Study of Simultaneous Boost Intensity-Modulated Radiotherapy for Locally Advanced Cervical Cancer

CompletedNCT01230996

Barts & The London NHS TrustLocally Advanced Cervical Cancer

Start: 2010-07-31End: 2018-07-31Updated: 2019-04-24

Phase 2

Short-Course Radiotherapy Combined with Intracavitary Brachytherapy Followed by Pucotenlimab, Bevacizumab, Oxaliplatin, and Trifluridine/Tipiracil (TAS-102) for Total Neoadjuvant Therapy of Microsatellite Stable (MSS) Locally Advanced Low Rectal Cancer

Not yet recruitingNCT06872606

Sir Run Run Shaw HospitalRectal Adenocarcinoma

Start: 2025-04-01End: 2028-04-01Target: 33Updated: 2025-03-12

Phase 3

Pelvic RT Versus Prophylactic Extended-field RT in Patients With Cervical Cancer

Peking Union Medical College HospitalUterine Cervical Neoplasms

Start: 2019-06-17End: 2025-06-01Target: 638Updated: 2022-02-23

Unknown Phase

Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer

Active, not recruitingNCT00185744

Stanford UniversityBreast Cancer, Carcinoma, Ductal

Start: 2002-09-01End: 2029-03-01Updated: 2026-03-20

Related Papers

Five-year results of a prospective clinical trial investigating accelerated partial breast irradiation using 3D conformal radiotherapy after lumpectomy for early stage breast cancer.

2016-06-176 citations